New progression of radiomics in diagnosis of gastric cancer

Abstract

CLC Number:

R735.2

ZHANG Huan, CHEN Yong. New progression of radiomics in diagnosis of gastric cancer[J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 42-48.

References69

[1]	BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424. doi:10.3322/caac.v68.6 URL
[2]	国家卫生健康委员会. 胃癌诊治指南(2022年版)[EB/OL]. 2022.http://www.nhc.gov.cn/yzygj/s7659/202204/a0e67177df1f439898683e1333957c74.shtml.
	National Health Commission. Guidelines for the diagnosis and treatment of gastric cancer (2022 edition)[EB/OL]. 2022.http://www.nhc.gov.cn/yzygj/s7659/202204/a0e67177df1f439898683e1333957c74.shtml.
[3]	LAMBIN P, RIOS-VELAZQUEZ E, LEIJENAAR R, et al. Radiomics: extracting more information from medical images using advanced feature analysis[J]. Eur J Cancer, 2012, 48(4):441-446. doi:10.1016/j.ejca.2011.11.036pmid:22257792
[4]	AMIN M B, GREENE F L, EDGE S B, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging[J]. CA Cancer J Clin, 2017, 67(2):93-99. doi:10.3322/caac.21388 URL
[5]	LORDICK F, CARNEIRO F, CASCINU S, et al. Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up[J]. Ann Oncol, 2022, 33(10):1005-1020. doi:10.1016/j.annonc.2022.07.004pmid:35914639
[6]	AJANI J A, D’AMICO T A, BENTREM D J, et al. Gastric Cancer, Version 2.2022, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2022, 20(2):167-192. doi:10.6004/jnccn.2022.0008 URL
[7]	WANG F H, ZHANG X T, LI Y F, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021[J]. Cancer Commun(London), 2021, 41(8):747-795.
[8]	CHANG X, GUO X, LI X, et al. Potential value of radiomics in the identification of stage T3 and T4a esophagogastric junction adenocarcinoma based on contrast-enhanced CT images[J]. Front Oncol, 2021, 11:627947. doi:10.3389/fonc.2021.627947 URL
[9]	SUN R J, FANG M J, TANG L, et al. CT-based deep learning radiomics analysis for evaluation of serosa invasion in advanced gastric cancer[J]. Eur J Radiol, 2020, 132:109277. doi:10.1016/j.ejrad.2020.109277 URL
[10]	PAN B, ZHANG W, CHEN W, et al. Establishment of the radiologic tumor invasion index based on radiomics splenic features and clinical factors to predict serous invasion of gastric cancer[J]. Front Oncol, 2021, 11:682456. doi:10.3389/fonc.2021.682456 URL
[11]	IMAOKA W, IDA K, KATOH T, et al. Is curative endoscopic treatment of early gastric cancer possible?[J]. Endoscopy, 1987, 19(Suppl 1):7-11.
[12]	HARTGRINK H H, VAN DE VELDE C J H, PUTTER H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial[J]. J Clin Oncol, 2004, 22(11):2069-2077. doi:10.1200/JCO.2004.08.026pmid:15082726
[13]	ZENG Q, LI H, ZHU Y, et al. Development and validation of a predictive model combining clinical, radiomics, and deep transfer learning features for lymph node metastasis in early gastric cancer[J]. Front Med(Lausanne), 2022, 9:986437.
[14]	CHEN W, WANG S, DONG D, et al. Evaluation of lymph node metastasis in advanced gastric cancer using magnetic resonance imaging-based radiomics[J]. Front Oncol, 2019, 9:1265. doi:10.3389/fonc.2019.01265pmid:31824847
[15]	FENG Q X, LIU C, QI L, et al. An intelligent clinical decision support system for preoperative prediction of lymph node metastasis in gastric cancer[J]. J Am Coll Radiol, 2019, 16(7):952-960. doi:10.1016/j.jacr.2018.12.017 URL
[16]	JIANG Y, WANG W, CHEN C, et al. Radiomics signature on computed tomography imaging: association with lymph node metastasis in patients with gastric cancer[J]. Front Oncol, 2019, 9:340. doi:10.3389/fonc.2019.00340pmid:31106158
[17]	LI J, DONG D, FANG M, et al. Dual-energy CT-based deep learning radiomics can improve lymph node metastasis risk prediction for gastric cancer[J]. Eur Radiol, 2020, 30(4):2324-2333. doi:10.1007/s00330-019-06621-xpmid:31953668
[18]	WANG Y, LIU W, YU Y, et al. CT radiomics nomogram for the preoperative prediction of lymph node metastasis in gastric cancer[J]. Eur Radiol, 2020, 30(2):976-986. doi:10.1007/s00330-019-06398-zpmid:31468157
[19]	YANG J, WU Q, XU L, et al. Integrating tumor and nodal radiomics to predict lymph node metastasis in gastric cancer[J]. Radiother Oncol, 2020, 150:89-96. doi:S0167-8140(20)30322-4pmid:32531334
[20]	LIU Q, LI J, XIN B, et al.¹⁸F-FDG PET/CT radiomics for preoperative prediction of lymph node metastases and nodal staging in gastric cancer[J]. Front Oncol, 2021, 11:723345. doi:10.3389/fonc.2021.723345 URL
[21]	MENG L, DONG D, CHEN X, et al. 2D and 3D CT radiomic features performance comparison in characterization of gastric cancer: a multi-center study[J]. IEEE J Biomed Health Inform, 2021, 25(3):755-763. doi:10.1109/JBHI.6221020 URL
[22]	SUN Z, JIANG Y, CHEN C, et al. Radiomics signature based on computed tomography images for the preoperative prediction of lymph node metastasis at individual stations in gastric cancer: a multicenter study[J]. Radiother Oncol, 2021, 165:179-190. doi:10.1016/j.radonc.2021.11.003pmid:34774652
[23]	WANG L, GONG J, HUANG X, et al. CT-based radiomics nomogram for preoperative prediction of No.10 lymph nodes metastasis in advanced proximal gastric cancer[J]. Eur J Surg Oncol, 2021, 47(6):1458-1465. doi:10.1016/j.ejso.2020.11.132pmid:33261951
[24]	WANG X, LI C, FANG M, et al.Integrating No.3 lymph nodes and primary tumor radiomics to predict lymph node metastasis in T1-2 gastric cancer[J]. BMC Med Imaging, 2021, 21(1):58. doi:10.1186/s12880-021-00587-3pmid:33757460
[25]	GUAN X, LU N, ZHANG J. Computed tomography-based deep learning nomogram can accurately predict lymph node metastasis in gastric cancer[J]. Dig Dis and Sci, 2022.
[26]	LI Y, XIE F, XIONG Q, et al. Machine learning for lymph node metastasis prediction of in patients with gastric cancer: a systematic review and meta-analysis[J]. Front Oncol, 2022, 12:946038. doi:10.3389/fonc.2022.946038 URL
[27]	XUE X Q, YU W J, SHAO X L, et al. Radiomics model based on preoperative¹⁸F-fluorodeoxyglucose PET predicts N2-3b lymph node metastasis in gastric cancer patients[J]. Nucl Med Commun, 2022, 43(3):340-349. doi:10.1097/MNM.0000000000001523 URL
[28]	SHIOZAKI H, ELIMOVA E, SLACK R S, et al. Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases[J]. J Surg Oncol, 2016, 113(1):29-35. doi:10.1002/jso.24087pmid:26603684
[29]	KURAMOTO M, SHIMADA S, IKESHIMA S, et al. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma[J]. Ann Surg, 2009, 250(2):242-246. doi:10.1097/SLA.0b013e3181b0c80epmid:19638909
[30]	HUANG J, CHEN Y, ZHANG Y, et al. Comparison of clinical-computed tomography model with 2D and 3D radiomics models to predict occult peritoneal metastases in advanced gastric cancer[J]. Abdom Radiol(NY), 2022, 47(1):66-75.
[31]	DONG D, TANG L, LI Z Y, et al. Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer[J]. Ann Oncol, 2019, 30(3):431-438. doi:S0923-7534(19)31081-6pmid:30689702
[32]	WANG L, LV P, XUE Z, et al. Novel CT based clinical nomogram comparable to radiomics model for identification of occult peritoneal metastasis in advanced gastric cancer[J]. Eur J Surg Oncol, 2022, 48(10):2166-2173. doi:10.1016/j.ejso.2022.06.034pmid:35817631
[33]	LIU S, HE J, LIU S, et al. Radiomics analysis using contrast-enhanced CT for preoperative prediction of occult peritoneal metastasis in advanced gastric cancer[J]. Eur Radiol, 2020, 30(1):239-246. doi:10.1007/s00330-019-06368-5pmid:31385045
[34]	CHEN Y, XI W, YAO W, et al. Dual-energy computed tomography-based radiomics to predict peritoneal metastasis in gastric cancer[J]. Front Oncol, 2021, 11:659981. doi:10.3389/fonc.2021.659981 URL
[35]	XUE B, JIANG J, CHEN L, et al. Development and validation of a radiomics model based on¹⁸F-FDG PET of primary gastric cancer for predicting peritoneal metastasis[J]. Front Oncol, 2021, 11:740111. doi:10.3389/fonc.2021.740111 URL
[36]	CUNNINGHAM D, ALLUM W H, STENNING S P, et al. Perioperative chemotherapyversussurgery alone for resectable gastroesophageal cancer[J]. N Engl J Med, 2006, 355(1):11-20. doi:10.1056/NEJMoa055531 URL
[37]	AL-BATRAN S E, HOMANN N, PAULIGK C, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxelversusfluorouracil or capecita-bine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial[J]. Lancet, 2019, 393(10184):1948-1957. doi:10.1016/S0140-6736(18)32557-1 URL
[38]	XU Q, SUN Z, LI X, et al. Advanced gastric cancer: CT radiomics prediction and early detection of downstaging with neoadjuvant chemotherapy[J]. Eur Radiol, 2021, 31(11):8765-8774. doi:10.1007/s00330-021-07962-2pmid:33909133
[39]	WANG L, ZHANG Y, CHEN Y, et al. The performance of a dual-energy CT derived radiomics model in differentiating serosal invasion for advanced gastric cancer patients after neoadjuvant chemotherapy: iodine map combined with 120-kV equivalent mixed images[J]. Front Oncol, 2020, 10:562945. doi:10.3389/fonc.2020.562945 URL
[40]	MA Z, FANG M, HUANG Y, et al. CT-based radiomics signature for differentiating Borrmann type Ⅳ gastric cancer from primary gastric lymphoma[J]. Eur J Radiol, 2017, 91:142-147. doi:10.1016/j.ejrad.2017.04.007 URL
[41]	FENG B, HUANG L, LIU Y, et al. A transfer learning radiomics nomogram for preoperative prediction of borrmann type Ⅳ gastric cancer from primary gastric lymphoma[J]. Front Oncol, 2021, 11:802205. doi:10.3389/fonc.2021.802205 URL
[42]	SUN Z Q, HU S D, LI J, et al. Radiomics study for differentiating gastric cancer from gastric stromal tumor based on contrast-enhanced CT images[J]. J Xray Sci Technol, 2019, 27(6):1021-1031.
[43]	Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma[J]. Nature, 2014, 513(7517):202-209. doi:10.1038/nature13480
[44]	ZHAO H, LI W, LYU P, et al. TCGA-TCIA-based CT radiomics study for noninvasively predicting epstein-barr virus status in gastric cancer[J]. Am J Roentgenol, 2021, 217(1):124-134. doi:10.2214/AJR.20.23534 URL
[45]	ZHANG C, WEN H L, ZHANG R, et al. Computed tomography radiomics to predict EBER positivity in Epstein-Barr virus-associated gastric adenocarcinomas: a retrospective study[J]. Acta Radiol, 2022, 63(8):1005-1013. doi:10.1177/02841851211029083 URL
[46]	BANG Y J, VAN CUTSEM E, FEYEREISLOVA A, et al. Trastuzumab in combination with chemotherapyversuschemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial[J]. Lancet, 2010, 376(9742):687-697. doi:10.1016/S0140-6736(10)61121-X URL
[47]	LI Y, CHENG Z, GEVAERT O, et al. A CT-based radiomics nomogram for prediction of human epidermal growth factor receptor 2 status in patients with gastric cancer[J]. Chin J Cancer Res, 2020, 32(1):62-71. doi:10.21147/j.issn.1000-9604.2020.01.08 URL
[48]	MA T, CUI J, WANG L, et al. A multiphase contrast-enhanced CT radiomics model for prediction of human epidermal growth factor receptor 2 status in advanced gastric cancer[J]. Front Genet, 2022, 13:968027. doi:10.3389/fgene.2022.968027 URL
[49]	GUAN X, LU N, ZHANG J. Evaluation of epidermal growth factor receptor 2 status in gastric cancer by CT-based deep learning radiomics nomogram[J]. Front Oncol, 2022, 12:905203. doi:10.3389/fonc.2022.905203 URL
[50]	LING Z Q, TANAKA A, LI P, et al. Microsatellite instabi-lity with promoter methylation and silencing of hMLH1 can regionally occur during progression of gastric carcinoma[J]. Cancer Lett, 2010, 297(2):244-251. doi:10.1016/j.canlet.2010.05.017 URL
[51]	CRISTESCU R, LEE J, NEBOZHYN M, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes[J]. Nat Med, 2015, 21(5):449-456. doi:10.1038/nm.3850pmid:25894828
[52]	VAN VELZEN M J M, DERKS S, VAN GRIEKEN N C T, et al. MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma[J]. Cancer Treat Rev, 2020, 86:102024. doi:10.1016/j.ctrv.2020.102024 URL
[53]	ZENG Q, ZHU Y, LI L, et al. CT-based radiomic nomogram for preoperative prediction of DNA mismatch repair deficiency in gastric cancer[J]. Front Oncol, 2022, 12:883109. doi:10.3389/fonc.2022.883109 URL
[54]	LIANG X, WU Y, LIU Y, et al. A multicenter study on the preoperative prediction of gastric cancer microsatellite instability status based on computed tomography radiomics[J]. Abdom Radiol(NY), 2022, 47(6):2036-2045.
[55]	TONG Y, LI J, CHEN J, et al. A radiomics nomogram integrated with clinic-radiological features for preoperative prediction of DNA mismatch repair deficiency in gastric adenocarcinoma[J]. Front Oncol, 2022, 12:865548. doi:10.3389/fonc.2022.865548 URL
[56]	ADACHI Y, YASUDA K, INOMATA M, et al. Pathology and prognosis of gastric carcinoma: wellversuspoorly differentiated type[J]. Cancer, 2000, 89(7):1418-1424. doi:10.1002/(ISSN)1097-0142 URL
[57]	HUANG H, XU F, CHEN Q, et al. The value of CT-based radiomics nomogram in differential diagnosis of different histological types of gastric cancer[J]. Phys Eng Sci Med, 2022, 45(4):1063-1071. doi:10.1007/s13246-022-01170-ypmid:36063347
[58]	SHI C, YU Y, YAN J, et al. The added value of radiomics from dual-energy spectral CT derived iodine-based material decomposition images in predicting histological grade of gastric cancer[J]. BMC Med imaging, 2022, 22(1):173. doi:10.1186/s12880-022-00899-ypmid:36192686
[59]	QIU M Z, CAI M Y, ZHANG D S, et al. Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China[J]. J Transl Med, 2013, 11:58. doi:10.1186/1479-5876-11-58
[60]	HU S B, LIU C H, WANG X, et al. Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer[J]. World J Surg Oncol, 2019, 17(1):3. doi:10.1186/s12957-018-1534-z
[61]	CHEN T, WU J, CUI C, et al. CT-based radiomics nomograms for preoperative prediction of diffuse-type and signet ring cell gastric cancer: a multicenter development and validation cohort[J]. J Transl Med, 2022, 20(1):38. doi:10.1186/s12967-022-03232-xpmid:35073917
[62]	WANG X X, DING Y, WANG S W, et al. Intratumoral and peritumoral radiomics analysis for preoperative Lauren classification in gastric cancer[J]. Cancer Imaging, 2020, 20(1):83. doi:10.1186/s40644-020-00358-3
[63]	WANG Y, LIU W, YU Y, et al. Potential value of CT radiomics in the distinction of intestinal-type gastric adenocarcinomas[J]. Eur Radiol, 2020, 30(5):2934-2944. doi:10.1007/s00330-019-06629-3pmid:32020404
[64]	SUN Z, JIN L, ZHANG S, et al. Preoperative prediction for lauren type of gastric cancer: a radiomics nomogram analysis based on CT images and clinical features[J]. J Xray Sci Technol, 2021, 29(4):675-686.
[65]	ZHENG H, ZHENG Q, JIANG M, et al. Contrast-enhanced CT based radiomics in the preoperative prediction of perineural invasion for patients with gastric cancer[J]. Eur J Radiol, 2022, 154:110393. doi:10.1016/j.ejrad.2022.110393 URL
[66]	CHEN X, YANG Z, YANG J, et al. Radiomics analysis of contrast-enhanced CT predicts lymphovascular invasion and disease outcome in gastric cancer: a preliminary study[J]. Cancer Imaging, 2020, 20(1):24. doi:10.1186/s40644-020-00302-5pmid:32248822
[67]	LI Q, FENG Q X, QI L, et al. Prognostic aspects of lymphovascular invasion in localized gastric cancer: new insights into the radiomics and deep transfer learning from contrast-enhanced CT imaging[J]. Abdom Radiol, 2022, 47(2):496-507. doi:10.1007/s00261-021-03309-z
[68]	FAN L, LI J, ZHANG H, et al. Machine learning analysis for the noninvasive prediction of lymphovascular invasion in gastric cancer using PET/CT and enhanced CT-based radiomics and clinical variables[J]. Abdom Radiol(NY), 2022, 47(4):1209-1222.
[69]	CHEN Q, ZHANG L, LIU S, et al. Radiomics in precision medicine for gastric cancer: opportunities and challenges[J]. Eur Radiol, 2022, 32(9):5852-5868. doi:10.1007/s00330-022-08704-8pmid:35316364

New progression of radiomics in diagnosis of gastric cancer

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References69

Related Articles15

Recommended Articles

Metrics

Comments

[1]	ZHU Zhenggang.Progress and prospect of surgical comprehensive treatment of gastric cancer[J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 1-6.
[2]	ZHAO Fazhi, ZHAO Ping.Formation and improvement of surgery-based treatment system for gastric cancer[J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 24-30.
[3]	LI Guoli, GUO Feilong.Preoperative chemotherapy through intra-arterial combined with intra-venous administration in treatment of advanced gastric cancer[J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 31-35.
[4]	LIU Wentao, LIU Fukun.Summary and prospect of perioperative comprehensive treatment for gastric cancer in China[J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 36-41.
[5]	DENG Shijie, YUAN Fei.Advances in diagnosis and molecular detection of EBV-positive gastric cancer and gastric cancer with lymphoid stroma[J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 53-57.
[6]	LI Jianfang, YU Junxian, YAN Chao, ZHU Zhenggang, LIU Bingya.Hotspots in basic and translational research of gastric cancer[J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 7-16.
[7]	LU Yiming, XIONG Jianping, TIAN Yantao.Current status and prospect of conversion therapy for far-advanced gastric cancer[J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 17-23.
[8]	LIU Hongyuan, GU Hao, YANG Xi, et al. Sequencing analysis on tissue DNA from 55 patients with venous malformations and lymphatic malformations[J]. Journal of Tissue Engineering and Reconstructive Surgery, 2022, 18(3): 209-.
[9]	DAI Zhiqiang, ZHENG Jinxin, TANG Zhaoqing, ZHANG Qi, GU Yuan, SHI Zhongyi, HU Guohua, SUN Yihong.Metastatic lymph node ratio to evaluate prognosis of patients with stage Ⅱ-Ⅲ gastric cancer after radical gastrectomy[J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 429-434.
[10]	YANG Ruixin, DU Yutong, YAN Ranlin, ZHU Zhenggang, LI Chen, YU Yingyan.Improving exploration of biological sample pretreatment in single-cell transcriptome sequencing of gastrointestinal tumors[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(05): 567-574.
[11]	ZHAO Liqin, GUO Weijian, YU Nuoya, WU Junwei, ZHANG Jun.Effects of activin A on migration and aerobic glycolysis of gastric cancer cells[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 317-323.
[12]	LI Nana, QI Tao, ZHU Liming.Clinical value of serum pepsinogen,gastrin 17 andHelicobacter pyloriIgG antibody in primary screening of gastric diseases[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 509-513.
[13]	NIE Mingming, ZHU Zhenggang.Clinical significance of diagnostic laparoscopy on precision staging in advanced gastric cancer[J]. Journal of Surgery Concepts & Practice, 2022, 27(04): 365-370.
[14]	GUO Liangqi, YAN Zhilong, ZHANG Moucheng.Laparoscopic intragastric surgery in treating of gastric submucosal tumor and early gastric cancer[J]. Journal of Surgery Concepts & Practice, 2022, 27(04): 380-383.
[15]	DU Yanran, JIAO Jing, REN Yunyun, ZHOU Jianqiao.Application of ultrasound-based radiomics technology in the evaluation of fetal lung maturity[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(03): 326-330.